SHEN, Yuli

Adjunct Clinical Lecturer

教育背景

Master (Guangzhou Medical University)

研究领域
Chronic kidney diseases, hyperuricemia, hemedialysis and Immune dysfunction.
电子邮件
71005168@qq.com
个人简介

Shen Yuli graduated from Guangzhou Medical University with Master’s degree of internal medicine, and joined the second affiliated hospital of The Chinese University of Hong Kong in 2015. She had worked as a visiting fellow in Department of Nephrology, Klinikum rechts der Isar, Technische Universitat München for one year(2020). Her research area related to chronic kidney diseases, hyperuricemia and  immune dysfunction of hemodialysis. She is the youth member of Plasma Purification Committee of Guangdong Clinical Association and Nephrology Committee of Shenzhen Medical Association. She is the secretary of nephrology committee of Longgang Medical Association.

学术著作

1.Liu Y, Sun D, Huang Y, Shen Y, Chen T, Chen W, Zhu L, Wang F, Hong G, Luo Y et al: Bibliometric analysis of research on retinoic acid in the field of kidney disorders. Frontiers in pharmacology 2024, 15:1435889.
2.Shen Y, Schmaderer C, Ossadnik A, Hammitzsch A, Carbajo-Lozoya J, Bachmann Q, Bonell V, Braunisch MC, Heemann U, Pham D et al: Immunophenotypic Characterization of Citrate-Containing A Concentrates in Maintenance Hemodialysis: A Pre-Post Study. International journal of nephrology 2023, 2023:7772677.
3.Lorenz G, Shen Y, Hausinger RI, Scheid C, Eckermann M, Hornung S, Cardoso J, Lech M, Ribeiro A, Haller B et al: A randomized prospective cross over study on the effects of medium cut-off membranes on T cellular and serologic immune phenotypes in hemodialysis. Scientific reports 2022, 12(1):16419.
4.Guo Z, Shen Y, Zhong J, Li Z, Guo Q, Yao X, Wang Y, Wu W: RIP140-Mediated NF-κB Inflammatory Pathway Promotes Metabolic Dysregulation in Retinal Pigment Epithelium Cells. Current issues in molecular biology 2022, 44(11):5788-5801.
5.Wu W, He S, Shen Y, Zhang J, Wan Y, Tang X, Liu S, Yao X: Natural Product Luteolin Rescues THAP-Induced Pancreatic β-Cell Dysfunction through HNF4α Pathway. The American journal of Chinese medicine 2020, 48(6):1435-1454.